The proposed research project addresses how the zymogen prothrombin is converted to the mature protease thrombin. The project is aimed at gaining a mechanistic understanding of this key reaction of the blood coagulation cascade using a combination of x-ray structural biology, kinetics, site-directed mutagenesis and fluorescence measurements at the single molecule level. Specifically, the project builds on our recent success in the crystallization of prothrombin and the discovery of its conformational flexibility due to the linkers connecting the Gla domain, kringles and protease domain and will address the following basic questions: What is the role of prothrombin flexibility in the function of the zymogen? How does the conformation of prothrombin change upon binding to the prothrombinase complex and its components? What is the role of the linkers in controlling the conformation of the zymogen, as well as the rate and pathway of activation? What are the regions of prothrombin important for the conversion to the mature enzyme thrombin? The project consists of the following specific aims: 1. Elucidate the role of conformational flexibilit in the structure and function of prothrombin; 2. Identify the epitopes that control the rate and pathway of prothrombin activation.
In specific aim 1, we will build on recent breakthrough structures of prothrombin to attach fluorescence dyes at various positions across the length of the zymogen to enable single molecule measurements of the conformations in solution when free and bound to the prothrombinase complex and its components. We will endeavor to elucidate the role of flexible linkers connecting the Gla domain to kringle-1 (Lnk1), kringle-1 to kringle-2 (Lnk2), and kringle-2 to the A chain (Lnk3) in controlling the conformation of prothrombin. We hypothesize that the linkers, and especially Lnk2, play a dominant role in controlling the rate and pathway of prothrombin activation by changing their conformation upon interaction with the prothrombinase complex and its components. Developments under this specific aim will provide unprecedented details on the structural changes that accompany prothrombin activation.
In specific aim 2, we will complement the studies under specific aim 1 with an Ala scanning mutagenesis mapping of residues controlling the rate and pathway of prothrombin activation. The scan will be guided by available structural information and will target charged and aromatic residues >70% exposed to solvent, as well as residues whose naturally occurring mutations are associated with bleeding phenotypes. We hypothesize that the linkers orchestrate the spatial arrangement of specific domains of prothrombin to optimize the rate of activation and dictate selection of the pathway by prothrombinase. Developments under this specific aim will identify epitopes responsible for prothrombin activation that will offer targets or therapeutic intervention and afford a molecular interpretation of the bleeding phenotypes associated with many naturally occurring mutations.

Public Health Relevance

Recent statistics indicate that cardiovascular disease and its thrombotic complications will remain the leading cause of death and disability and will represent a major burden to productivity in the US and worldwide well into the year 2020. Because of its involvement in thrombotic deaths, thrombin and its precursor prothrombin remain major targets of antithrombotic and anticoagulant therapies. Progress in the understanding of how prothrombin is activated to thrombin will benefit our knowledge of a key reaction of the blood coagulation cascade and inform new strategies of therapeutic intervention that could influence the life-style and life expectancy of millions of people in the US and worldwide.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Hemostasis and Thrombosis Study Section (HT)
Program Officer
Warren, Ronald Q
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Saint Louis University
Schools of Medicine
Saint Louis
United States
Zip Code
Chinnaraj, Mathivanan; Chen, Zhiwei; Pelc, Leslie A et al. (2018) Structure of prothrombin in the closed form reveals new details on the mechanism of activation. Sci Rep 8:2945
Chakraborty, Pradipta; Acquasaliente, Laura; Pelc, Leslie A et al. (2018) Interplay between conformational selection and zymogen activation. Sci Rep 8:4080
Mickevi?i?t?, Aurelija; Timm, David D; Gedgaudas, Marius et al. (2018) Intrinsic thermodynamics of high affinity inhibitor binding to recombinant human carbonic anhydrase IV. Eur Biophys J 47:271-290
Sivaraja, Mohanram; Pozzi, Nicola; Rienzo, Matthew et al. (2018) Reversible covalent direct thrombin inhibitors. PLoS One 13:e0201377
Barranco-Medina, Sergio; Murphy, Mary; Pelc, Leslie et al. (2017) Rational Design of Protein C Activators. Sci Rep 7:44596
Chakraborty, Pradipta; Di Cera, Enrico (2017) Induced Fit Is a Special Case of Conformational Selection. Biochemistry 56:2853-2859
Pozzi, Nicola; Bystranowska, Dominika; Zuo, Xiaobing et al. (2016) Structural Architecture of Prothrombin in Solution Revealed by Single Molecule Spectroscopy. J Biol Chem 291:18107-16
Pozzi, Nicola; Zerbetto, Mirco; Acquasaliente, Laura et al. (2016) Loop Electrostatics Asymmetry Modulates the Preexisting Conformational Equilibrium in Thrombin. Biochemistry 55:3984-94
Eickhoff, Christopher S; Zhang, Xiuli; Vasconcelos, Jose R et al. (2016) Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity. PLoS Pathog 12:e1005896
Wu, Xiaobin; Kim, Heejeong; Seravalli, Javier et al. (2016) Potassium and the K+/H+ Exchanger Kha1p Promote Binding of Copper to ApoFet3p Multi-copper Ferroxidase. J Biol Chem 291:9796-806

Showing the most recent 10 out of 55 publications